Consumers satisfaction with pharmaceutical services in community pharmacies in Benghazi-Libya

Background: The pharmacist, as a front-line provider, is always in contact with patients who come to the pharmacy for various reasons. This study aimed to determine patients’ satisfaction with pharmaceutical services provided by community pharmacists. Methods: An anonymous, pre-piloted questionnaire-based study was conducted in Benghazi, Libya. Data were analyzed using SPSS, and results were expressed as frequency and percentage of respondents. Results: A total of 281 completed questionnaires were received back. The majority (196, 69%) of respondents were female. The respondents were of different age groups, but most of them were between 17 and 24 (65.1%) years old. Over 50% of the participants were students (159, 56.6%). The majority of participants find the pharmacist helpful (96%), and 77% of the participants have categorized the pharmacist as a salesman. Most of the participants ask the pharmacist about how to use a medical device, the dose of medication, the frequency of use, the duration of treatment, and the side effects of the medication. Patients (113, 4.2%) do not ask the pharmacist because the physician provided information. Conclusions: The results of the present study showed a moderate level of patient satisfaction with the help provided by the community pharmacist. However, the pharmacist needs to fully practice his or her role to the advantage of the patients, and the latter needs to be aware of what to expect and demand from the community pharmacist

Rescue treatment in patients with poorly responsive Guillain–Barre syndrome

Objectives: To evaluate the effectiveness of rescue treatment (intravenous immunoglobulin or plasma exchange) in patients with Guillain–Barre syndrome who did not respond or deteriorated after the initial management with intravenous immunoglobulin. Methods: We performed a retrospective review of the medical records of patients who responded poorly or did not respond to intravenous immunoglobulin treatment. The disability parameters of those who received second-line treatment with intravenous immunoglobulin or plasma exchange (20 patients) were compared with those who did not receive second-line treatment (19 patients). Results: There was a statistically significant improvement in disability scores at 1 month in the patients who received the rescue treatment (p = 0.033). However, there was no significant difference in the disability scores at 3 and 6 months, or in length of intensive care unit stay. Conclusion: Our study showed that a second course of treatment to carefully selected patients may be beneficia